Groth resigns as Bioheart CEO

Karl Groth resigned as chairman and director of Bioheart, and has been replaced by William Murphy, Jr., according to a filing with the Securities and Exchange Commission. It gave no reason for his departure. Story

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.